肾癌-话题@MedSci

#肾癌#

9篇内容 | 3290人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=916395, encodeId=098b91639510, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, objectType=article, longId=205718, objectId=9075205e18ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610258817277_5295905.jpg, objectUrl=/article/show_article.do?id=9075205e18ad, replyNumber=0, likeNumber=291, createdTime=2021-01-14, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9075205e18ad, moduleTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9075205e18ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=916383, encodeId=44df916383e9, content=<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a><a href='/topic/show?id=3ad9818917c' target=_blank style='color:#2F92EE;'>#肥胖#</a>, objectTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, objectType=article, longId=205718, objectId=9075205e18ad, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610258817277_5295905.jpg, objectUrl=/article/show_article.do?id=9075205e18ad, replyNumber=0, likeNumber=285, createdTime=2021-01-13, rootId=0, userName=Nebula-Qin, userId=74c72110107, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9075205e18ad, moduleTitle=J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9075205e18ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=915874, encodeId=a0a59158e47d, content=<a href='/topic/show?id=fffe10411443' target=_blank style='color:#2F92EE;'>#阿昔替尼联合派姆单抗#</a>＆<a href='/topic/show?id=8f5c82594d5' target=_blank style='color:#2F92EE;'>#肾癌#</a>, objectTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, objectType=article, longId=205645, objectId=b54a2056457f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021111/1610374641055_2110107.JPG, objectUrl=/article/show_article.do?id=b54a2056457f, replyNumber=0, likeNumber=212, createdTime=2021-01-12, rootId=0, userName=zb1235672, userId=59321624668, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b54a2056457f, moduleTitle=Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b54a2056457f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肾癌

2020-05-29

zb1235672

#肾癌#

J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效

2021-01-14

Nebula-Qin

#肾癌##肥胖#

J Immunother Cancer：肥胖会减弱肾癌患者采用抗PD-1免疫治疗的疗效

2021-01-13

zb1235672

#阿昔替尼联合派姆单抗#＆#肾癌#

Eur J Cancer：阿昔替尼联合派姆单抗治疗晚期肾癌的长期随访预后良好！

2021-01-12